CELEMICS Trademark

Trademark Overview


On Tuesday, May 30, 2023, a trademark application was filed for CELEMICS with the United States Patent and Trademark Office. The USPTO has given the CELEMICS trademark a serial number of 98018569. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, September 24, 2024. This trademark is owned by CELEMICS, Inc.. The CELEMICS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Biotechnological preparations, namely, reagents for medical purposes; pharmaceutical preparations for activating cellular function for the treatment of cancer, infectious disease, autoimmune disease, cardiovascular disease, and allergy; chemical preparations for pharmaceutical purposes, namely, for cancer, infectious disease, autoimmune disease, cardiovascular disease, and allergy; chemical preparations for medical purposes, namely, for cancer, infectious disease, autoimmune disease, cardiovascular disease, and allergy; siccatives being drying agents for medical purposes; reagents for in-vitro laboratory use for medical purposes; cleansing solutions for medical use; reagents for medical use; drugs for medical purposes, namely, pharmaceutical preparations for the treatment of cancer, infectious disease, autoimmune disease, cardiovascular disease, and allergy; enzymes for medical purposes; enzyme preparations for medical purposes; nucleic acid sequences for medical and veterinary purpose...

Research and development of DNA chips; structural and functional analysis of genomes; scientific laboratory services; advisory services relating to scientific research; providing information relating to scientific research; advisory services relating to biotechnology; research relating to biotechnology; biological research services; biochemical analysis; biochemistry research services; scientific research in the field of gene analysis; customized genetic scientific research; pharmaceutical research; medical research; clinical research in the field of oncology, cardiovascular disease neurology, immunology, and genomics; blood testing for scientific research purposes; consultancy in analysis of biology sequence processing for medical research purposes; consultancy in analysis of genomics for medical research purposes; scientific research in the fields of biomedicine; scientific research for medical purposes in the field of cancerous diseases; scientific research for medical purposes in t...
celemics

General Information


Serial Number98018569
Word MarkCELEMICS
Filing DateTuesday, May 30, 2023
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, September 24, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, July 30, 2024

Trademark Statements


Description of MarkThe mark consists of the word "CELEMICS" with a helix to the left of the word.
Goods and ServicesBiotechnological preparations, namely, reagents for medical purposes; pharmaceutical preparations for activating cellular function for the treatment of cancer, infectious disease, autoimmune disease, cardiovascular disease, and allergy; chemical preparations for pharmaceutical purposes, namely, for cancer, infectious disease, autoimmune disease, cardiovascular disease, and allergy; chemical preparations for medical purposes, namely, for cancer, infectious disease, autoimmune disease, cardiovascular disease, and allergy; siccatives being drying agents for medical purposes; reagents for in-vitro laboratory use for medical purposes; cleansing solutions for medical use; reagents for medical use; drugs for medical purposes, namely, pharmaceutical preparations for the treatment of cancer, infectious disease, autoimmune disease, cardiovascular disease, and allergy; enzymes for medical purposes; enzyme preparations for medical purposes; nucleic acid sequences for medical and veterinary purposes; chemical preparations for use in DNA analysis for medical purposes, namely, for cancer, infectious disease, autoimmune disease, cardiovascular disease, and allergy; in vitro diagnostic preparations for medical purposes; diagnostic test reagents for medical or veterinary purposes; biological and chemical reagents for medical or veterinary purposes; reagents for use in medical genetic testing; reagents for use in veterinary genetic testing.
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesResearch and development of DNA chips; structural and functional analysis of genomes; scientific laboratory services; advisory services relating to scientific research; providing information relating to scientific research; advisory services relating to biotechnology; research relating to biotechnology; biological research services; biochemical analysis; biochemistry research services; scientific research in the field of gene analysis; customized genetic scientific research; pharmaceutical research; medical research; clinical research in the field of oncology, cardiovascular disease neurology, immunology, and genomics; blood testing for scientific research purposes; consultancy in analysis of biology sequence processing for medical research purposes; consultancy in analysis of genomics for medical research purposes; scientific research in the fields of biomedicine; scientific research for medical purposes in the field of cancerous diseases; scientific research for medical purposes in the area of cancerous diseases; chemical research; research for medical products, namely, medical research; scientific research in the nature of conducting clinical trials for others in the field of oncology, cardiovascular disease, neurology, immunology, and genomics; biotechnology research; biochemical research; providing information of scientific research.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, June 29, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, June 29, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCELEMICS, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSeoul, 08506
KR

Party NameCELEMICS, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSeoul, 08506
KR

Trademark Events


Event DateEvent Description
Friday, June 30, 2023NOTICE OF DESIGN SEARCH CODE E-MAILED
Friday, June 2, 2023NEW APPLICATION ENTERED
Thursday, June 29, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, March 1, 2024NON-FINAL ACTION WRITTEN
Thursday, February 22, 2024ASSIGNED TO EXAMINER
Friday, March 1, 2024NON-FINAL ACTION E-MAILED
Friday, March 1, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, May 27, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, June 12, 2024EXAMINERS AMENDMENT -WRITTEN
Wednesday, June 12, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, June 12, 2024EXAMINER'S AMENDMENT ENTERED
Wednesday, June 12, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, May 27, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, May 27, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, June 12, 2024EXAMINERS AMENDMENT E-MAILED
Wednesday, July 10, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 30, 2024PUBLISHED FOR OPPOSITION
Tuesday, July 30, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 24, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT